Latest Commercialization News

Rhythm Biosciences has fast-tracked the integration of the geneType™ business, restoring full commercial capabilities ahead of schedule and setting the stage for expanded market reach.

Nufarm Limited’s 2025 AGM revealed a resilient FY24 performance despite industry headwinds, with strong growth in omega-3 canola and strategic cost-saving initiatives setting the stage for future expansion.

Micro-X Limited has requested an immediate voluntary suspension of its shares on the ASX, pending a forthcoming equity raising announcement expected by February 10.

OncoSil Medical has secured authorization for 120 German hospitals to negotiate funding for its pancreatic cancer treatment device, marking a 43% increase from last year and signaling growing acceptance in Germany’s healthcare system.

Nufarm’s 2025 AGM revealed a resilient FY24 performance despite industry headwinds, with strategic investments in omega-3 canola, biofuels, and cost-saving initiatives setting the stage for growth in FY25.

Athena Resources has appointed Peter Jones as Managing Director and CEO, aiming to leverage his extensive Mid-West iron ore experience to advance the high-grade Byro Magnetite Project.

WAT Resources Ltd has successfully produced ferroniobium from its Luni niobium concentrate, marking a key milestone in the West Arunta Project’s development. The proof-of-concept testwork confirms the viability of a conventional production process and sets the stage for further optimisation and product diversification.

Entyr Limited has received a $3.79 million R&D tax incentive payment for its innovative thermal desorption project targeting rubber waste, reinforcing its position in sustainable tyre recycling technology.

Redivium Limited’s recent entitlement offer failed to meet the minimum subscription, leading to its cancellation and full refunds to investors. The company now pivots towards a green bond funding strategy to support its battery recycling ambitions.

Cue Energy Resources has pushed back the deadline for its gas supply agreement with Arafura from early February to the end of March 2025, signaling a critical timeline shift for the Nolans rare earths project.

Alpha HPA Limited has announced key leadership changes, appointing Rob Williamson as Managing Director to steer the company through its next growth phase, while Rimas Kairaitis shifts focus to commercial strategy. The retirement of long-serving director Peter Nightingale marks the end of an era.

Alpha HPA Limited has announced key leadership changes, appointing Rob Williamson as Managing Director and repositioning Rimas Kairaitis as Executive Director and Chief Commercial Officer to support its next growth phase.